nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.137	0.248	CbGbCtD
Alfuzosin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.103	0.188	CbGbCtD
Alfuzosin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0888	0.161	CbGbCtD
Alfuzosin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0876	0.159	CbGbCtD
Alfuzosin—CYP3A4—Prednisone—ankylosing spondylitis	0.0827	0.15	CbGbCtD
Alfuzosin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0517	0.0938	CbGbCtD
Alfuzosin—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00223	0.00497	CcSEcCtD
Alfuzosin—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00222	0.00493	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.00221	0.00492	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.00221	0.00492	CcSEcCtD
Alfuzosin—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00219	0.00487	CcSEcCtD
Alfuzosin—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00213	0.00474	CcSEcCtD
Alfuzosin—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00208	0.00463	CcSEcCtD
Alfuzosin—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00207	0.0046	CcSEcCtD
Alfuzosin—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00203	0.00452	CcSEcCtD
Alfuzosin—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00202	0.0045	CcSEcCtD
Alfuzosin—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00201	0.00447	CcSEcCtD
Alfuzosin—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00196	0.00437	CcSEcCtD
Alfuzosin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00195	0.00435	CcSEcCtD
Alfuzosin—Angioedema—Prednisolone—ankylosing spondylitis	0.00193	0.0043	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00193	0.00429	CcSEcCtD
Alfuzosin—Breast disorder—Methotrexate—ankylosing spondylitis	0.00193	0.00429	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00192	0.00427	CcSEcCtD
Alfuzosin—Malaise—Prednisolone—ankylosing spondylitis	0.00191	0.00424	CcSEcCtD
Alfuzosin—Vertigo—Prednisolone—ankylosing spondylitis	0.0019	0.00423	CcSEcCtD
Alfuzosin—Syncope—Prednisolone—ankylosing spondylitis	0.0019	0.00422	CcSEcCtD
Alfuzosin—Eye disorder—Betamethasone—ankylosing spondylitis	0.00189	0.00421	CcSEcCtD
Alfuzosin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00189	0.00421	CcSEcCtD
Alfuzosin—Back pain—Triamcinolone—ankylosing spondylitis	0.00188	0.00419	CcSEcCtD
Alfuzosin—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00186	0.00414	CcSEcCtD
Alfuzosin—Angiopathy—Betamethasone—ankylosing spondylitis	0.00184	0.00409	CcSEcCtD
Alfuzosin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00184	0.00409	CcSEcCtD
Alfuzosin—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.0018	0.00401	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.0018	0.00401	CcSEcCtD
Alfuzosin—Discomfort—Prednisolone—ankylosing spondylitis	0.00178	0.00396	CcSEcCtD
Alfuzosin—Angioedema—Triamcinolone—ankylosing spondylitis	0.00178	0.00395	CcSEcCtD
Alfuzosin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00177	0.00394	CcSEcCtD
Alfuzosin—Malaise—Triamcinolone—ankylosing spondylitis	0.00175	0.0039	CcSEcCtD
Alfuzosin—Malaise—Methylprednisolone—ankylosing spondylitis	0.00175	0.00389	CcSEcCtD
Alfuzosin—Vertigo—Triamcinolone—ankylosing spondylitis	0.00175	0.00389	CcSEcCtD
Alfuzosin—Syncope—Triamcinolone—ankylosing spondylitis	0.00174	0.00388	CcSEcCtD
Alfuzosin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00174	0.00388	CcSEcCtD
Alfuzosin—Syncope—Methylprednisolone—ankylosing spondylitis	0.00174	0.00387	CcSEcCtD
Alfuzosin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00173	0.00386	CcSEcCtD
Alfuzosin—Oedema—Prednisolone—ankylosing spondylitis	0.00172	0.00384	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00171	0.00381	CcSEcCtD
Alfuzosin—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00171	0.0038	CcSEcCtD
Alfuzosin—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.0017	0.00379	CcSEcCtD
Alfuzosin—Shock—Prednisolone—ankylosing spondylitis	0.0017	0.00378	CcSEcCtD
Alfuzosin—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.0017	0.00378	CcSEcCtD
Alfuzosin—Tachycardia—Prednisolone—ankylosing spondylitis	0.00168	0.00375	CcSEcCtD
Alfuzosin—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00167	0.00371	CcSEcCtD
Alfuzosin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00165	0.00368	CcSEcCtD
Alfuzosin—Eye disorder—Prednisone—ankylosing spondylitis	0.00165	0.00367	CcSEcCtD
Alfuzosin—Drowsiness—Methotrexate—ankylosing spondylitis	0.00164	0.00366	CcSEcCtD
Alfuzosin—Infestation—Methotrexate—ankylosing spondylitis	0.00164	0.00366	CcSEcCtD
Alfuzosin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00164	0.00366	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00164	0.00365	CcSEcCtD
Alfuzosin—Flushing—Prednisone—ankylosing spondylitis	0.00164	0.00365	CcSEcCtD
Alfuzosin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00164	0.00364	CcSEcCtD
Alfuzosin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00164	0.00364	CcSEcCtD
Alfuzosin—Discomfort—Triamcinolone—ankylosing spondylitis	0.00163	0.00364	CcSEcCtD
Alfuzosin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00163	0.00363	CcSEcCtD
Alfuzosin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00162	0.0036	CcSEcCtD
Alfuzosin—Angioedema—Dexamethasone—ankylosing spondylitis	0.00161	0.00359	CcSEcCtD
Alfuzosin—Angioedema—Betamethasone—ankylosing spondylitis	0.00161	0.00359	CcSEcCtD
Alfuzosin—Angiopathy—Prednisone—ankylosing spondylitis	0.0016	0.00356	CcSEcCtD
Alfuzosin—Malaise—Betamethasone—ankylosing spondylitis	0.00159	0.00354	CcSEcCtD
Alfuzosin—Malaise—Dexamethasone—ankylosing spondylitis	0.00159	0.00354	CcSEcCtD
Alfuzosin—Oedema—Triamcinolone—ankylosing spondylitis	0.00159	0.00353	CcSEcCtD
Alfuzosin—Vertigo—Betamethasone—ankylosing spondylitis	0.00158	0.00353	CcSEcCtD
Alfuzosin—Vertigo—Dexamethasone—ankylosing spondylitis	0.00158	0.00353	CcSEcCtD
Alfuzosin—Syncope—Betamethasone—ankylosing spondylitis	0.00158	0.00352	CcSEcCtD
Alfuzosin—Syncope—Dexamethasone—ankylosing spondylitis	0.00158	0.00352	CcSEcCtD
Alfuzosin—Infection—Triamcinolone—ankylosing spondylitis	0.00158	0.00351	CcSEcCtD
Alfuzosin—Sweating—Methotrexate—ankylosing spondylitis	0.00157	0.00351	CcSEcCtD
Alfuzosin—Infection—Methylprednisolone—ankylosing spondylitis	0.00157	0.0035	CcSEcCtD
Alfuzosin—Shock—Triamcinolone—ankylosing spondylitis	0.00156	0.00347	CcSEcCtD
Alfuzosin—Shock—Methylprednisolone—ankylosing spondylitis	0.00156	0.00347	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00155	0.00346	CcSEcCtD
Alfuzosin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00155	0.00346	CcSEcCtD
Alfuzosin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00155	0.00345	CcSEcCtD
Alfuzosin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00155	0.00345	CcSEcCtD
Alfuzosin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00155	0.00345	CcSEcCtD
Alfuzosin—Mental disorder—Prednisone—ankylosing spondylitis	0.00155	0.00344	CcSEcCtD
Alfuzosin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00154	0.00344	CcSEcCtD
Alfuzosin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00154	0.00342	CcSEcCtD
Alfuzosin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00153	0.00341	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00153	0.00341	CcSEcCtD
Alfuzosin—Discomfort—Dexamethasone—ankylosing spondylitis	0.00148	0.0033	CcSEcCtD
Alfuzosin—Discomfort—Betamethasone—ankylosing spondylitis	0.00148	0.0033	CcSEcCtD
Alfuzosin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00148	0.00329	CcSEcCtD
Alfuzosin—Pain—Prednisolone—ankylosing spondylitis	0.00148	0.00328	CcSEcCtD
Alfuzosin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00146	0.00326	CcSEcCtD
Alfuzosin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00146	0.00324	CcSEcCtD
Alfuzosin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00145	0.00322	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00145	0.00322	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00144	0.00321	CcSEcCtD
Alfuzosin—Oedema—Dexamethasone—ankylosing spondylitis	0.00144	0.0032	CcSEcCtD
Alfuzosin—Oedema—Betamethasone—ankylosing spondylitis	0.00144	0.0032	CcSEcCtD
Alfuzosin—Infection—Dexamethasone—ankylosing spondylitis	0.00143	0.00318	CcSEcCtD
Alfuzosin—Infection—Betamethasone—ankylosing spondylitis	0.00143	0.00318	CcSEcCtD
Alfuzosin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00143	0.00317	CcSEcCtD
Alfuzosin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00142	0.00316	CcSEcCtD
Alfuzosin—Shock—Dexamethasone—ankylosing spondylitis	0.00142	0.00315	CcSEcCtD
Alfuzosin—Shock—Betamethasone—ankylosing spondylitis	0.00142	0.00315	CcSEcCtD
Alfuzosin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00141	0.00314	CcSEcCtD
Alfuzosin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00141	0.00314	CcSEcCtD
Alfuzosin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00141	0.00314	CcSEcCtD
Alfuzosin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00141	0.00314	CcSEcCtD
Alfuzosin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.0014	0.00313	CcSEcCtD
Alfuzosin—Tachycardia—Betamethasone—ankylosing spondylitis	0.0014	0.00313	CcSEcCtD
Alfuzosin—Angioedema—Prednisone—ankylosing spondylitis	0.0014	0.00312	CcSEcCtD
Alfuzosin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.0014	0.00311	CcSEcCtD
Alfuzosin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00139	0.0031	CcSEcCtD
Alfuzosin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00139	0.0031	CcSEcCtD
Alfuzosin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00139	0.0031	CcSEcCtD
Alfuzosin—Malaise—Prednisone—ankylosing spondylitis	0.00139	0.00308	CcSEcCtD
Alfuzosin—Vertigo—Prednisone—ankylosing spondylitis	0.00138	0.00307	CcSEcCtD
Alfuzosin—Eye disorder—Methotrexate—ankylosing spondylitis	0.00138	0.00307	CcSEcCtD
Alfuzosin—Syncope—Prednisone—ankylosing spondylitis	0.00138	0.00307	CcSEcCtD
Alfuzosin—Urticaria—Prednisolone—ankylosing spondylitis	0.00137	0.00305	CcSEcCtD
Alfuzosin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00137	0.00305	CcSEcCtD
Alfuzosin—Fatigue—Triamcinolone—ankylosing spondylitis	0.00137	0.00304	CcSEcCtD
Alfuzosin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00136	0.00304	CcSEcCtD
Alfuzosin—Pain—Triamcinolone—ankylosing spondylitis	0.00136	0.00302	CcSEcCtD
Alfuzosin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00135	0.00301	CcSEcCtD
Alfuzosin—Hypotension—Dexamethasone—ankylosing spondylitis	0.00134	0.00299	CcSEcCtD
Alfuzosin—Hypotension—Betamethasone—ankylosing spondylitis	0.00134	0.00299	CcSEcCtD
Alfuzosin—Angiopathy—Methotrexate—ankylosing spondylitis	0.00134	0.00298	CcSEcCtD
Alfuzosin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00133	0.00296	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00131	0.00292	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00131	0.00292	CcSEcCtD
Alfuzosin—Arthralgia—Prednisone—ankylosing spondylitis	0.00131	0.00291	CcSEcCtD
Alfuzosin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00131	0.00291	CcSEcCtD
Alfuzosin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0013	0.0029	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.0013	0.00289	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00129	0.00288	CcSEcCtD
Alfuzosin—Discomfort—Prednisone—ankylosing spondylitis	0.00129	0.00288	CcSEcCtD
Alfuzosin—Mental disorder—Methotrexate—ankylosing spondylitis	0.00129	0.00288	CcSEcCtD
Alfuzosin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00127	0.00282	CcSEcCtD
Alfuzosin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00127	0.00282	CcSEcCtD
Alfuzosin—Urticaria—Triamcinolone—ankylosing spondylitis	0.00126	0.00281	CcSEcCtD
Alfuzosin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00126	0.0028	CcSEcCtD
Alfuzosin—Oedema—Prednisone—ankylosing spondylitis	0.00125	0.00279	CcSEcCtD
Alfuzosin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00125	0.00279	CcSEcCtD
Alfuzosin—Infection—Prednisone—ankylosing spondylitis	0.00125	0.00277	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00124	0.00277	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00124	0.00277	CcSEcCtD
Alfuzosin—Back pain—Methotrexate—ankylosing spondylitis	0.00124	0.00276	CcSEcCtD
Alfuzosin—Fatigue—Dexamethasone—ankylosing spondylitis	0.00124	0.00276	CcSEcCtD
Alfuzosin—Fatigue—Betamethasone—ankylosing spondylitis	0.00124	0.00276	CcSEcCtD
Alfuzosin—Shock—Prednisone—ankylosing spondylitis	0.00123	0.00275	CcSEcCtD
Alfuzosin—Pain—Betamethasone—ankylosing spondylitis	0.00123	0.00274	CcSEcCtD
Alfuzosin—Pain—Dexamethasone—ankylosing spondylitis	0.00123	0.00274	CcSEcCtD
Alfuzosin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00123	0.00274	CcSEcCtD
Alfuzosin—Tachycardia—Prednisone—ankylosing spondylitis	0.00122	0.00272	CcSEcCtD
Alfuzosin—Skin disorder—Prednisone—ankylosing spondylitis	0.00122	0.00271	CcSEcCtD
Alfuzosin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00121	0.0027	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00119	0.00265	CcSEcCtD
Alfuzosin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00119	0.00264	CcSEcCtD
Alfuzosin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00119	0.00264	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00118	0.00262	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00118	0.00262	CcSEcCtD
Alfuzosin—Malaise—Methotrexate—ankylosing spondylitis	0.00116	0.00258	CcSEcCtD
Alfuzosin—Vertigo—Methotrexate—ankylosing spondylitis	0.00115	0.00257	CcSEcCtD
Alfuzosin—Urticaria—Dexamethasone—ankylosing spondylitis	0.00114	0.00255	CcSEcCtD
Alfuzosin—Urticaria—Betamethasone—ankylosing spondylitis	0.00114	0.00255	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00114	0.00254	CcSEcCtD
Alfuzosin—Dizziness—Prednisolone—ankylosing spondylitis	0.00114	0.00254	CcSEcCtD
Alfuzosin—Asthenia—Triamcinolone—ankylosing spondylitis	0.00114	0.00253	CcSEcCtD
Alfuzosin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00114	0.00253	CcSEcCtD
Alfuzosin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00114	0.00253	CcSEcCtD
Alfuzosin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00114	0.00253	CcSEcCtD
Alfuzosin—Pruritus—Triamcinolone—ankylosing spondylitis	0.00112	0.0025	CcSEcCtD
Alfuzosin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00112	0.00249	CcSEcCtD
Alfuzosin—Dyspepsia—Prednisone—ankylosing spondylitis	0.0011	0.00246	CcSEcCtD
Alfuzosin—Chest pain—Methotrexate—ankylosing spondylitis	0.00109	0.00243	CcSEcCtD
Alfuzosin—Arthralgia—Methotrexate—ankylosing spondylitis	0.00109	0.00243	CcSEcCtD
Alfuzosin—Rash—Prednisolone—ankylosing spondylitis	0.00109	0.00242	CcSEcCtD
Alfuzosin—Dermatitis—Prednisolone—ankylosing spondylitis	0.00109	0.00242	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00109	0.00242	CcSEcCtD
Alfuzosin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00108	0.00241	CcSEcCtD
Alfuzosin—Fatigue—Prednisone—ankylosing spondylitis	0.00108	0.00241	CcSEcCtD
Alfuzosin—Headache—Prednisolone—ankylosing spondylitis	0.00108	0.00241	CcSEcCtD
Alfuzosin—Discomfort—Methotrexate—ankylosing spondylitis	0.00108	0.0024	CcSEcCtD
Alfuzosin—Constipation—Prednisone—ankylosing spondylitis	0.00107	0.00239	CcSEcCtD
Alfuzosin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00105	0.00234	CcSEcCtD
Alfuzosin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00105	0.00233	CcSEcCtD
Alfuzosin—Infection—Methotrexate—ankylosing spondylitis	0.00104	0.00232	CcSEcCtD
Alfuzosin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00103	0.0023	CcSEcCtD
Alfuzosin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00103	0.0023	CcSEcCtD
Alfuzosin—Asthenia—Betamethasone—ankylosing spondylitis	0.00103	0.0023	CcSEcCtD
Alfuzosin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00103	0.00229	CcSEcCtD
Alfuzosin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00103	0.00228	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00103	0.00228	CcSEcCtD
Alfuzosin—Nausea—Prednisolone—ankylosing spondylitis	0.00102	0.00228	CcSEcCtD
Alfuzosin—Pruritus—Betamethasone—ankylosing spondylitis	0.00102	0.00227	CcSEcCtD
Alfuzosin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00102	0.00227	CcSEcCtD
Alfuzosin—Skin disorder—Methotrexate—ankylosing spondylitis	0.00102	0.00227	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00101	0.00225	CcSEcCtD
Alfuzosin—Vomiting—Triamcinolone—ankylosing spondylitis	0.00101	0.00225	CcSEcCtD
Alfuzosin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00101	0.00224	CcSEcCtD
Alfuzosin—Rash—Triamcinolone—ankylosing spondylitis	0.001	0.00223	CcSEcCtD
Alfuzosin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000999	0.00222	CcSEcCtD
Alfuzosin—Rash—Methylprednisolone—ankylosing spondylitis	0.000998	0.00222	CcSEcCtD
Alfuzosin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000997	0.00222	CcSEcCtD
Alfuzosin—Urticaria—Prednisone—ankylosing spondylitis	0.000996	0.00222	CcSEcCtD
Alfuzosin—Headache—Triamcinolone—ankylosing spondylitis	0.000994	0.00221	CcSEcCtD
Alfuzosin—Headache—Methylprednisolone—ankylosing spondylitis	0.000992	0.00221	CcSEcCtD
Alfuzosin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000991	0.00221	CcSEcCtD
Alfuzosin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000985	0.00219	CcSEcCtD
Alfuzosin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000985	0.00219	CcSEcCtD
Alfuzosin—Hypotension—Methotrexate—ankylosing spondylitis	0.000979	0.00218	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000954	0.00212	CcSEcCtD
Alfuzosin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000952	0.00212	CcSEcCtD
Alfuzosin—Dizziness—Betamethasone—ankylosing spondylitis	0.000952	0.00212	CcSEcCtD
Alfuzosin—Nausea—Triamcinolone—ankylosing spondylitis	0.000942	0.0021	CcSEcCtD
Alfuzosin—Nausea—Methylprednisolone—ankylosing spondylitis	0.00094	0.00209	CcSEcCtD
Alfuzosin—Somnolence—Methotrexate—ankylosing spondylitis	0.000931	0.00207	CcSEcCtD
Alfuzosin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000922	0.00205	CcSEcCtD
Alfuzosin—Vomiting—Betamethasone—ankylosing spondylitis	0.000915	0.00204	CcSEcCtD
Alfuzosin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000915	0.00204	CcSEcCtD
Alfuzosin—Rash—Dexamethasone—ankylosing spondylitis	0.000908	0.00202	CcSEcCtD
Alfuzosin—Rash—Betamethasone—ankylosing spondylitis	0.000908	0.00202	CcSEcCtD
Alfuzosin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000907	0.00202	CcSEcCtD
Alfuzosin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000907	0.00202	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000904	0.00201	CcSEcCtD
Alfuzosin—Fatigue—Methotrexate—ankylosing spondylitis	0.000903	0.00201	CcSEcCtD
Alfuzosin—Headache—Dexamethasone—ankylosing spondylitis	0.000902	0.00201	CcSEcCtD
Alfuzosin—Headache—Betamethasone—ankylosing spondylitis	0.000902	0.00201	CcSEcCtD
Alfuzosin—Asthenia—Prednisone—ankylosing spondylitis	0.000899	0.002	CcSEcCtD
Alfuzosin—Pain—Methotrexate—ankylosing spondylitis	0.000896	0.00199	CcSEcCtD
Alfuzosin—Pruritus—Prednisone—ankylosing spondylitis	0.000887	0.00197	CcSEcCtD
Alfuzosin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000863	0.00192	CcSEcCtD
Alfuzosin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000858	0.00191	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000857	0.00191	CcSEcCtD
Alfuzosin—Nausea—Dexamethasone—ankylosing spondylitis	0.000855	0.0019	CcSEcCtD
Alfuzosin—Nausea—Betamethasone—ankylosing spondylitis	0.000855	0.0019	CcSEcCtD
Alfuzosin—Urticaria—Methotrexate—ankylosing spondylitis	0.000832	0.00185	CcSEcCtD
Alfuzosin—Dizziness—Prednisone—ankylosing spondylitis	0.000829	0.00185	CcSEcCtD
Alfuzosin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000828	0.00184	CcSEcCtD
Alfuzosin—Vomiting—Prednisone—ankylosing spondylitis	0.000797	0.00177	CcSEcCtD
Alfuzosin—Rash—Prednisone—ankylosing spondylitis	0.00079	0.00176	CcSEcCtD
Alfuzosin—Dermatitis—Prednisone—ankylosing spondylitis	0.00079	0.00176	CcSEcCtD
Alfuzosin—Headache—Prednisone—ankylosing spondylitis	0.000785	0.00175	CcSEcCtD
Alfuzosin—Asthenia—Methotrexate—ankylosing spondylitis	0.000752	0.00167	CcSEcCtD
Alfuzosin—Nausea—Prednisone—ankylosing spondylitis	0.000745	0.00166	CcSEcCtD
Alfuzosin—Pruritus—Methotrexate—ankylosing spondylitis	0.000741	0.00165	CcSEcCtD
Alfuzosin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000717	0.0016	CcSEcCtD
Alfuzosin—Dizziness—Methotrexate—ankylosing spondylitis	0.000693	0.00154	CcSEcCtD
Alfuzosin—Vomiting—Methotrexate—ankylosing spondylitis	0.000666	0.00148	CcSEcCtD
Alfuzosin—Rash—Methotrexate—ankylosing spondylitis	0.000661	0.00147	CcSEcCtD
Alfuzosin—Dermatitis—Methotrexate—ankylosing spondylitis	0.00066	0.00147	CcSEcCtD
Alfuzosin—Headache—Methotrexate—ankylosing spondylitis	0.000656	0.00146	CcSEcCtD
Alfuzosin—Nausea—Methotrexate—ankylosing spondylitis	0.000622	0.00139	CcSEcCtD
